BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38279262)

  • 1. Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models.
    Miao T; Symonds A; Hickman OJ; Wu D; Wang P; Lemoine N; Wang Y; Linardopoulos S; Halldén G
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells.
    Man YKS; Davies JA; Coughlan L; Pantelidou C; Blázquez-Moreno A; Marshall JF; Parker AL; Halldén G
    Mol Cancer Ther; 2018 Feb; 17(2):575-587. PubMed ID: 29367266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in oncolytic adenovirus therapy for pancreatic cancer.
    Nattress CB; Halldén G
    Cancer Lett; 2018 Oct; 434():56-69. PubMed ID: 29981812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models.
    Rodríguez MDCR; Rodríguez IG; Nattress C; Qureshi A; Halldén G
    Viruses; 2022 May; 14(5):. PubMed ID: 35632748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models.
    Man YKS; Aguirre-Hernandez C; Fernandez A; Martin-Duque P; González-Pastor R; Halldén G
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma.
    Bots STF; Harryvan TJ; Groeneveldt C; Kinderman P; Kemp V; van Montfoort N; Hoeben RC
    Mol Oncol; 2024 May; 18(5):1245-1258. PubMed ID: 38037840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Adenovirus Expressing ST13 Increases Antitumor Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Against Pancreatic Ductal Adenocarcinoma.
    Zhang Y; Ye M; Huang F; Wang S; Wang H; Mou X; Wang Y
    Hum Gene Ther; 2020 Aug; 31(15-16):891-903. PubMed ID: 32475172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses.
    Raimondi G; Mato-Berciano A; Pascual-Sabater S; Rovira-Rigau M; Cuatrecasas M; Fondevila C; Sánchez-Cabús S; Begthel H; Boj SF; Clevers H; Fillat C
    EBioMedicine; 2020 Jun; 56():102786. PubMed ID: 32460166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors.
    Gayral M; Lulka H; Hanoun N; Biollay C; Sèlves J; Vignolle-Vidoni A; Berthommé H; Trempat P; Epstein AL; Buscail L; Béjot JL; Cordelier P
    Hum Gene Ther; 2015 Feb; 26(2):104-13. PubMed ID: 25423447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.
    Chu QD; Sun G; Pope M; Luraguiz N; Curiel DT; Kim R; Li BD; Mathis JM
    Surgery; 2012 Sep; 152(3):441-8. PubMed ID: 22853858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
    Hastie E; Cataldi M; Moerdyk-Schauwecker MJ; Felt SA; Steuerwald N; Grdzelishvili VZ
    Oncotarget; 2016 Sep; 7(38):61601-61618. PubMed ID: 27533247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers.
    Oberg D; Yanover E; Adam V; Sweeney K; Costas C; Lemoine NR; Halldén G
    Clin Cancer Res; 2010 Jan; 16(2):541-53. PubMed ID: 20068104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors.
    Yamamoto Y; Nagasato M; Rin Y; Henmi M; Ino Y; Yachida S; Ohki R; Hiraoka N; Tagawa M; Aoki K
    Cancer Med; 2017 Oct; 6(10):2385-2397. PubMed ID: 28941156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects.
    Bazan-Peregrino M; Garcia-Carbonero R; Laquente B; Álvarez R; Mato-Berciano A; Gimenez-Alejandre M; Morgado S; Rodríguez-García A; Maliandi MV; Riesco MC; Moreno R; Ginestà MM; Perez-Carreras M; Gornals JB; Prados S; Perea S; Capella G; Alemany R; Salazar R; Blasi E; Blasco C; Cascallo M; Hidalgo M
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 35149591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.
    Sahai V; Kumar K; Knab LM; Chow CR; Raza SS; Bentrem DJ; Ebine K; Munshi HG
    Mol Cancer Ther; 2014 Jul; 13(7):1907-17. PubMed ID: 24807963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
    Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
    Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity.
    Bofill-De Ros X; Gironella M; Fillat C
    Mol Ther; 2014 Sep; 22(9):1665-77. PubMed ID: 24895996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma.
    Zhang L; Wang W; Wang R; Zhang N; Shang H; Bi Y; Chen D; Zhang C; Li L; Yin J; Zhang H; Cao Y
    Mol Ther; 2021 Feb; 29(2):744-761. PubMed ID: 33130310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
    Seegers SL; Frasier C; Greene S; Nesmelova IV; Grdzelishvili VZ
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.